ME/CFS and long COVID; negative outcomes for ALS drug; donanemab
Neurology Today in 518 Huhti 2024

ME/CFS and long COVID; negative outcomes for ALS drug; donanemab

Neurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that explores an association between myalgic encephalomyelitis/chronic fatigue and long COVID; negative phase 3 findings on AMX0035 for ALS, and the pending approval of donanemab for Alzheimer's disease.

Jaksot(100)

November 4- Issue Introduction

November 4- Issue Introduction

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the November 4, 2021 issue.

8 Marras 20215min

October 21- Issue Introduction

October 21- Issue Introduction

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the October 21, 2021 issue.

21 Loka 20215min

October 7- Issue Introduction

October 7- Issue Introduction

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the October 7, 2021 issue.

7 Loka 20215min

September 16- Issue Introduction

September 16- Issue Introduction

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the September 16, 2021 issue.

16 Syys 20215min

Suosittua kategoriassa Premium

nikotellen
tuplakaak
antin-matka
jaljilla
anni-jaajo
ihan-oikeesti
olipa-kerran-otsikko
hei-baby-3
dear-shirly
maanantaimysteeri
terveisia-perheesta
aikalisa
palmujen-varjoissa
i-dont-like-mondays
sita
siita-on-vaikea-puhua
the-harlin-show
piinan-kirous-2
tahtitehdas
grekovit